Bloomios Shareholder Update & Growth Strategy
Bloomios, Inc. (OTC: BLMS) provided a shareholder update on November 17, 2021, outlining its growth strategy since going public in April 2021. The company aims to be a leader in hemp-derived products, offering over 220 customizable products. Recent investments in manufacturing capabilities, including a new gummy machine, are expected to enhance output by 3-5 times. The company anticipates approximately $9 million in gross revenue in its first operational year, aiming for breakeven or a slight loss while pursuing acquisitions for market expansion.
- Projected gross revenue of approximately $9 million in the first full operational year.
- Plans to increase manufacturing output by 3-5 times with new machinery and software.
- Ongoing due diligence on several acquisition targets to expand market reach.
- None.
SANTA BARBARA, Calif., Nov. 17, 2021 /PRNewswire/ -- Bloomios, Inc. (OTC: BLMS), CEO, Michael Hill issued the following letter to shareholders, providing an update on the Company's developments and future growth strategy.
Dear Shareholders, It is with immense pride that I present this update on our recent corporate activities and strategic initiatives to you.
Bloomios went public in April 2021. Bloomios was founded with the belief that high quality and affordable hemp-derived products should be accessible to those in the U.S. who need it to improve their daily activities. We are determined to become the leading hemp-derived products manufacturer, supporting the industry's most recognized brands.
Bloomios manufactures, markets and distributes U.S. hemp-derived supplements and cosmetic products via wholesale distribution channels, manufactured by its wholly owned subsidiary Bloomios Private Label. We provide services including custom formulation, brand development and order fulfillment to a wide variety of customers including both large and small brands, chain stores, vape shops and distributors. We offer our private-label and white-label customers a large array of custom formulations and manufacturing services with over 220 hemp products across 12 categories.
Bloomios' recent financings and cashflow have provided for the Company's acquisition of new software and hardware to further improve our manufacturing capabilities and our operational efficiencies. More specifically, the Company purchased a new infused gummy machine, a new high-production printer, additional packaging equipment, software systems and many other items. This expansion and automation should allow the Company to increase output by 3-5 times our current manufacturing capabilities. We also continue to bolster our management team and now have 70 full-time employees.
Bloomios believes that our first full year in operation, we will hit approximately
Additionally, Bloomios is focused on the vertical integration of targeted brand acquisitions enabling us to address the wider consumer direct market. Through the addition of brand acquisitions, organic development, and distribution channel partnerships we intend to offer a full suite of high-quality consumer products. The Company is currently conducting due diligence on several acquisition targets.
The Bloomios management team is committed to continuing to execute our growth and acquisition strategy to increase long term shareholder value by building profitable revenue.
We value all our shareholders. If you have any questions or concerns, please do not hesitate to contact us at the following address: investorrelations@bloomios.com
About Bloomios Inc.
Bloomios manufactures, markets and distributes U.S. hemp-derived supplements and cosmetic products through wholesale distribution channels, through its wholly owned subsidiary Bloomios Private Label. The Company provides services including custom formulation, brand development and order fulfillment to a wide variety of customers including small and major brands, chain stores, vape shops and distributors. Offering our private-label and white-label customers large collections of customizable hemp products that includes over 220 products across 12 categories in addition to custom formulation and manufacturing services. Bloomios is headquartered in Santa Barbara, California with its operations in Daytona Beach, Florida. To learn more: https://www.bloomios.com
Safe Harbor Statement:
Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the sales of the company's identity protection software products into various channels and market sectors, the issuance of the Company's pending patent applications, COVID-19, and the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, the impact on the national and local economies resulting from terrorist actions, and U.S. actions subsequently; and other factors detailed in reports filed by the company.
Bloomios Contact Info:
Michael Hill, CEO
investorrelations@bloomios.com
(805) 222-6330
View original content to download multimedia:https://www.prnewswire.com/news-releases/bloomios-shareholder-update--growth-strategy-301427031.html
SOURCE Bloomios, Inc.
FAQ
What is Bloomios' projected revenue for the first operational year?
When did Bloomios go public?
What are Bloomios' growth plans?
How much has Bloomios invested in improving manufacturing?
What is the current employee count at Bloomios?
